Last edition
News about "oligonucleotide-based therapeutics"
Cohance Lifesciences Invests INR 23 Cr on New cGMP Oligonucleotide Facility at Hyderabad
Cohance Lifesciences has announced an investment of INR 230 million and significant progress on its new cGMP oligonucleotide building block manufacturing facility in Hyderabad, India.
Oligonucleotide-based Therapeutics | 13/08/2025 | By Dineshwori | 103
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members